The STEP trials, which evaluated semaglutide, followed patients for up to three years in extension studies, showing that weight loss plateaus rather than reverses when treatment continues as prescribed
I think that there is general agreement that these medications cost too much and not enough people have access to them, but I think very few people think that compounding them solves the problem due to the safety risks, he says
For patients seeking non-pharmaceutical approaches to enhance incretin function, comprehensive lifestyle modifications remain the foundation of evidence-based care
Soluble fiber fermentation by gut bacteria produces short-chain fatty acids, particularly butyrate, that directly stimulate GLP-1 secretion
Start your intake Understanding Mochi's Telehealth Model and GLP-1 Offerings Mochi is a direct-to-consumer telehealth platform launched to streamline GLP-1 access through simplified, affordable consultations